glutathione kills triple negative cancer overproduction mediates lymphoma initiating cells survival and has a sex-dependent effect on lymphomagenesis Tumor-targeted glutathione oxidation catalysis with
Tumor targeted glutathione oxidation catalysis with ruthenium nanoreactors against hypoxic osteosarcoma Nature Communications Frontiers Patterns of immune evasion in triple negative breast cancer and new potential therapeutic targets: a review Glutathione responsive nanomedicine leverages tumor redox imbalance for targeted cancer theranostics Discover Oncology Springer Nature Link A review of biological targets and therapeutic approaches in the management of triple negative breast cancer ScienceDirect Frontiers Glutathione responsive and exhausting metal nanomedicines for robust synergistic cancer therapy
Pay in 4 interest-free payments of $5.22 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15




